BR9106751A - Oligonucleotideo ou analogo de nucleotideo e processo para modulacao da atividade de uma infeccao por citomegalovirus - Google Patents
Oligonucleotideo ou analogo de nucleotideo e processo para modulacao da atividade de uma infeccao por citomegalovirusInfo
- Publication number
- BR9106751A BR9106751A BR919106751A BR9106751A BR9106751A BR 9106751 A BR9106751 A BR 9106751A BR 919106751 A BR919106751 A BR 919106751A BR 9106751 A BR9106751 A BR 9106751A BR 9106751 A BR9106751 A BR 9106751A
- Authority
- BR
- Brazil
- Prior art keywords
- oligonucleotide
- cmv
- modulating
- citomegalovirus
- infection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1133—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against herpetoviridae, e.g. HSV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/322—2'-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
- C12N2310/3521—Methyl
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56836690A | 1990-08-16 | 1990-08-16 | |
PCT/US1991/005815 WO1992003456A1 (en) | 1990-08-16 | 1991-08-14 | Oligonucleotides for modulating the effects of cytomegalovirus infections |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9106751A true BR9106751A (pt) | 1993-08-17 |
Family
ID=24270996
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR919106751A BR9106751A (pt) | 1990-08-16 | 1991-08-14 | Oligonucleotideo ou analogo de nucleotideo e processo para modulacao da atividade de uma infeccao por citomegalovirus |
BR1100909-8A BR1100909A (pt) | 1990-08-16 | 1997-05-14 | Oligonucleotìdeo |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR1100909-8A BR1100909A (pt) | 1990-08-16 | 1997-05-14 | Oligonucleotìdeo |
Country Status (16)
Country | Link |
---|---|
US (1) | US5591720A (pt) |
EP (1) | EP0544713B1 (pt) |
JP (1) | JP2708960B2 (pt) |
KR (1) | KR970005273B1 (pt) |
AT (1) | ATE154947T1 (pt) |
AU (1) | AU649717B2 (pt) |
BR (2) | BR9106751A (pt) |
CA (1) | CA2089666C (pt) |
DE (1) | DE69126710T2 (pt) |
DK (1) | DK0544713T3 (pt) |
ES (1) | ES2104717T3 (pt) |
FI (1) | FI930658A0 (pt) |
GR (1) | GR3024873T3 (pt) |
HU (1) | HUT63430A (pt) |
NO (1) | NO930515L (pt) |
WO (1) | WO1992003456A1 (pt) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1223831A (en) | 1982-06-23 | 1987-07-07 | Dean Engelhardt | Modified nucleotides, methods of preparing and utilizing and compositions containing the same |
US5789573A (en) * | 1990-08-14 | 1998-08-04 | Isis Pharmaceuticals, Inc. | Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2 |
US5595978A (en) * | 1990-08-16 | 1997-01-21 | Isis Pharmaceuticals, Inc. | Composition and method for treatment of CMV retinites |
US6153595A (en) * | 1990-08-16 | 2000-11-28 | Isis Pharmaceuticals Inc. | Composition and method for treatment of CMV infections |
US7119184B2 (en) | 1991-08-12 | 2006-10-10 | Isis Pharmaceuticals, Inc. | Oligonucleotides having A-DNA form and B-DNA form conformational geometry |
US6369209B1 (en) | 1999-05-03 | 2002-04-09 | Isis Pharmaceuticals, Inc. | Oligonucleotides having A-DNA form and B-DNA form conformational geometry |
EP0693126B9 (en) * | 1993-04-02 | 2007-09-12 | Rigel Pharmaceuticals, Inc. | Method for selective inactivation of viral replication |
US6824976B1 (en) | 1993-04-02 | 2004-11-30 | Rigel Pharmaceuticals, Inc. | Method for selective inactivation of viral replication |
US6727230B1 (en) | 1994-03-25 | 2004-04-27 | Coley Pharmaceutical Group, Inc. | Immune stimulation by phosphorothioate oligonucleotide analogs |
US5801235A (en) * | 1994-05-25 | 1998-09-01 | Hybridon, Inc. | Oligonucleotides with anti-cytomegalovirus activity |
US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
ATE420171T1 (de) | 1994-07-15 | 2009-01-15 | Univ Iowa Res Found | Immunomodulatorische oligonukleotide |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
WO1997033992A1 (en) * | 1996-03-14 | 1997-09-18 | Hybridon, Inc. | Selected oligonucleotides with anti-cytomegalovirus activity |
WO1997048795A2 (en) * | 1996-06-18 | 1997-12-24 | Hybridon, Inc. | Compositions and methods for treating specific gene expression-related diseases and disorders in humans |
EP0855184A1 (en) | 1997-01-23 | 1998-07-29 | Grayson B. Dr. Lipford | Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination |
US6172209B1 (en) | 1997-02-14 | 2001-01-09 | Isis Pharmaceuticals Inc. | Aminooxy-modified oligonucleotides and methods for making same |
US6127533A (en) | 1997-02-14 | 2000-10-03 | Isis Pharmaceuticals, Inc. | 2'-O-aminooxy-modified oligonucleotides |
US6576752B1 (en) | 1997-02-14 | 2003-06-10 | Isis Pharmaceuticals, Inc. | Aminooxy functionalized oligomers |
US6214806B1 (en) | 1997-02-28 | 2001-04-10 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CPC dinucleotide in the treatment of LPS-associated disorders |
US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
WO1998046740A1 (en) * | 1997-04-17 | 1998-10-22 | Antivirals, Inc. | Method of treating restenosis by antisense targeting of cmv |
CA2301575C (en) | 1997-05-20 | 2003-12-23 | Ottawa Civic Hospital Loeb Research Institute | Vectors and methods for immunization or therapeutic protocols |
US5877309A (en) | 1997-08-13 | 1999-03-02 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotides against JNK |
US20070149472A1 (en) * | 1997-08-13 | 2007-06-28 | Mckay Robert | Antisense oligonucleotide compositions and methods for the modulation of jnk proteins |
US6133246A (en) * | 1997-08-13 | 2000-10-17 | Isis Pharmaceuticals Inc. | Antisense oligonucleotide compositions and methods for the modulation of JNK proteins |
DE69935507T2 (de) | 1998-04-03 | 2007-12-06 | University Of Iowa Research Foundation | Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine |
US6841539B1 (en) * | 1998-05-21 | 2005-01-11 | Isis Pharmaceuticals, Inc. | Compositions and methods for topical delivery of oligonucleotides |
US6242589B1 (en) | 1998-07-14 | 2001-06-05 | Isis Pharmaceuticals, Inc. | Phosphorothioate oligonucleotides having modified internucleoside linkages |
US6277967B1 (en) | 1998-07-14 | 2001-08-21 | Isis Pharmaceuticals, Inc. | Carbohydrate or 2′-modified oligonucleotides having alternating internucleoside linkages |
US6867294B1 (en) * | 1998-07-14 | 2005-03-15 | Isis Pharmaceuticals, Inc. | Gapped oligomers having site specific chiral phosphorothioate internucleoside linkages |
US6335194B1 (en) | 1998-09-29 | 2002-01-01 | Isis Pharmaceuticals, Inc. | Antisense modulation of survivin expression |
US6077709A (en) | 1998-09-29 | 2000-06-20 | Isis Pharmaceuticals Inc. | Antisense modulation of Survivin expression |
ID30093A (id) | 1999-02-12 | 2001-11-01 | Sankyo Co | Analog-analog nukleosida dan oligonukleotida baru |
JP4151751B2 (ja) * | 1999-07-22 | 2008-09-17 | 第一三共株式会社 | 新規ビシクロヌクレオシド類縁体 |
US6147200A (en) * | 1999-08-19 | 2000-11-14 | Isis Pharmaceuticals, Inc. | 2'-O-acetamido modified monomers and oligomers |
US6949520B1 (en) | 1999-09-27 | 2005-09-27 | Coley Pharmaceutical Group, Inc. | Methods related to immunostimulatory nucleic acid-induced interferon |
DK1446162T3 (da) | 2001-08-17 | 2008-12-08 | Coley Pharm Gmbh | Kombinationsmotiv-immunstimulatoriske oligonukleotider med forbedret aktivitet |
KR20040008342A (ko) * | 2002-07-18 | 2004-01-31 | 한국전력공사 | 산업용 보일러의 화학세정시 발생하는 폐액 재활용 방법 |
US20050196382A1 (en) * | 2002-09-13 | 2005-09-08 | Replicor, Inc. | Antiviral oligonucleotides targeting viral families |
AU2003267785C1 (en) * | 2002-09-13 | 2009-12-24 | Replicor, Inc. | Non-sequence complementary antiviral oligonucleotides |
US7998492B2 (en) | 2002-10-29 | 2011-08-16 | Coley Pharmaceutical Group, Inc. | Methods and products related to treatment and prevention of hepatitis C virus infection |
CA2533701A1 (en) | 2003-07-31 | 2005-02-17 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
US20140189895A1 (en) | 2011-07-22 | 2014-07-03 | Yoshindo Inc. | TECHNIQUE FOR CLEAVING OUT PART OF POLY(A) CHAIN AND/OR 3'-TERMINAL SEQUENCE OF mRNA TO INHIBIT TRANSLATION REACTION |
US20180036409A1 (en) | 2014-12-29 | 2018-02-08 | Bonac Corporation | Composition containing nucleic acid molecule stably |
EP3377636A4 (en) * | 2015-11-20 | 2019-11-06 | Oregon Health & Science University | CMV VECTORS WITH MIKRORNA DETECTION ELEMENTS |
US20210395746A1 (en) * | 2018-06-12 | 2021-12-23 | The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Glads | Compositions for herpesvirus transcriptional feedback circuit disruption and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5248670A (en) * | 1990-02-26 | 1993-09-28 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotides for inhibiting herpesviruses |
-
1991
- 1991-08-14 ES ES91914366T patent/ES2104717T3/es not_active Expired - Lifetime
- 1991-08-14 JP JP3513776A patent/JP2708960B2/ja not_active Expired - Lifetime
- 1991-08-14 KR KR1019930700439A patent/KR970005273B1/ko not_active IP Right Cessation
- 1991-08-14 EP EP91914366A patent/EP0544713B1/en not_active Expired - Lifetime
- 1991-08-14 CA CA002089666A patent/CA2089666C/en not_active Expired - Lifetime
- 1991-08-14 US US07/927,506 patent/US5591720A/en not_active Expired - Lifetime
- 1991-08-14 DE DE69126710T patent/DE69126710T2/de not_active Expired - Fee Related
- 1991-08-14 DK DK91914366.9T patent/DK0544713T3/da active
- 1991-08-14 WO PCT/US1991/005815 patent/WO1992003456A1/en active IP Right Grant
- 1991-08-14 BR BR919106751A patent/BR9106751A/pt not_active Application Discontinuation
- 1991-08-14 AU AU84393/91A patent/AU649717B2/en not_active Ceased
- 1991-08-14 HU HU93398A patent/HUT63430A/hu unknown
- 1991-08-14 AT AT91914366T patent/ATE154947T1/de not_active IP Right Cessation
-
1993
- 1993-02-12 NO NO93930515A patent/NO930515L/no unknown
- 1993-02-15 FI FI930658A patent/FI930658A0/fi not_active Application Discontinuation
-
1997
- 1997-05-14 BR BR1100909-8A patent/BR1100909A/pt active IP Right Grant
- 1997-09-26 GR GR970402519T patent/GR3024873T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
BR1100909A (pt) | 2000-06-06 |
DE69126710T2 (de) | 1998-01-15 |
CA2089666A1 (en) | 1992-02-17 |
AU649717B2 (en) | 1994-06-02 |
ES2104717T3 (es) | 1997-10-16 |
US5591720A (en) | 1997-01-07 |
NO930515D0 (no) | 1993-02-12 |
JPH06501841A (ja) | 1994-03-03 |
JP2708960B2 (ja) | 1998-02-04 |
DK0544713T3 (da) | 1997-09-29 |
AU8439391A (en) | 1992-03-17 |
FI930658A (fi) | 1993-02-15 |
NO930515L (no) | 1993-03-31 |
GR3024873T3 (en) | 1998-01-30 |
CA2089666C (en) | 2003-01-07 |
HUT63430A (en) | 1993-08-30 |
HU9300398D0 (en) | 1993-05-28 |
EP0544713A1 (en) | 1993-06-09 |
ATE154947T1 (de) | 1997-07-15 |
EP0544713A4 (en) | 1994-05-18 |
KR970005273B1 (ko) | 1997-04-15 |
FI930658A0 (fi) | 1993-02-15 |
EP0544713B1 (en) | 1997-07-02 |
WO1992003456A1 (en) | 1992-03-05 |
KR930701465A (ko) | 1993-06-11 |
DE69126710D1 (de) | 1997-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9106751A (pt) | Oligonucleotideo ou analogo de nucleotideo e processo para modulacao da atividade de uma infeccao por citomegalovirus | |
DE69433626D1 (de) | N-2 substituierte purine | |
DE69732911D1 (de) | Oligoribonukleotide und ribonucleasen zur spaltung von rns | |
BR9206049A (pt) | Composto, processos para preparar o composto, para o reconhecimento específico por sequência de um polinucleotídio de filamento duplo, para modular a expressão de um gene em um organismo, para tratar as condições associadas com produção de proteínas indesejada em um organismo, para induzir a degradação de DNA ou RNA em células de um organismo e para exterminar células ou vírus e composição farmacêutica | |
DE69133511D1 (de) | Zuckermodifizierte oligonukleotide zum erkennen und steuern der genexpression | |
ATE244506T1 (de) | Oligonukleotidmodulation der expression von multiwirkstoff-resistenz -assoziiertem protein | |
DE69627698T2 (de) | Eine in kaskaden verlaufende vervielfältigungsreaktion von nukleinsäuren | |
BR9106087A (pt) | Oligonucleotidio ou anologo de oligonucleotidio e processos para modular a atividade de um virus de perpes e para tratar um animal suspeito de ter uma infeccao de virus de herpes | |
DE69403642D1 (de) | 7-deazapurin modifizierte oligonukleotide | |
ATE138384T1 (de) | Olionukleotidalkylphosphonate und - phosphonothioate | |
BR9007892A (pt) | Oligonucleotideo ou analogo de oligonucleotideo,processos para modular a expressao de um papilomavirus,para modular os efeitos de uma infeccao provocada por papilomavirus em um animal e para detectar a presenca ou ausencia de papilomavirus e estojo para detectar a presenca ou ausencia de papilomavirus em uma amostra | |
ES2139578T3 (es) | Composiciones y procedimiento para modular la actividad del arn mediante la modificacion de la estructura protectora 5' del arn. | |
WO1998054313A3 (en) | Dna methyltransferase genomic sequences and antisense oligonucleotides | |
DE68926455D1 (de) | Verfahren zur identifizierung von bakterien | |
ATE465261T1 (de) | Integrin-gekoppelte kinase, ihre hemmstoffe und deren gebrauch für verfahren zur therapeutischen behandlung; gentherapie und bereitstellung von hemmstoffen, die als pseudosubstrate wirken | |
BR1100617A (pt) | Oligonucleotìdeo tendo seq id no: 22, processo para inibir a sìntese de moléculas de adesão intercelulare em uma célula, oligonucleotìdeo tendo seq id no: 1, 3, 4, 5, 7, 8, 9, 10, 11, 12, 13, 14, 15, 17, 20, 21, 23, 24, 25, 26 ou 27, processo para inibir a sìntese de moléculas de adesão intercelulare em uma célula compreendendo contactar a célula in vitro com um oligonucleotìdeo tendo seq id no: 1, 3, 4, 5, 7, 8, 9, 10, 11, 12, 13, 14, 15, 17, 20, 21, 23, 24, 25, 26 ou 27 | |
BR9106752A (pt) | Oligonucleotideo ou analogo de oligonucleotideo,processo para tratamento de uma infeccao por candida e processo para a modulacao da atividade de candida | |
NO965017L (no) | Oligonukleotider med anti-cytomegalovirus aktivitet | |
ES2171709T3 (es) | Nuevo procedimiento de secuenciacion por hibridacion de oligomeros. | |
DE69430740D1 (de) | ANTISENSE OLIGONNUKLEOTIDE DIE MIT DER mRNA CAP AKTIVITÄT INTERFERIEREN UND DIE TRANSLATION INHIBIEREN | |
ES2092568T3 (es) | Identificacion de nuevos farmacos y reactivos. | |
ATE212057T1 (de) | Ribozymstruktur die von den genomischen rns des hepatitis delta virus abgeleitet ist | |
ATE108834T1 (de) | Spezifische nukleinsäurefragmente des menschlichen villingens, ihre anwendung für diagnostische zwecke. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |